Skip to main content
. 2022 Jun 17;140(4):566–573. doi: 10.1590/1516-3180.2021.0668.R1.121121

Table 4. Comparison of clinical and laboratory characteristics at admission between patients with community-acquired acute kidney injury (C-AKI) and those with hospital-acquired acute kidney injury (H-AKI).

Variables C-AKI (n = 55) H-AKI (n = 48) P
n/median %/IQR n/median %/IQR
General characteristics:
Age (years) (mean ± SD) 61 ± 15 60 ± 14 0.678
Female 18 32.7% 17 35.4% 0.77
Male 37 67.3% 31 64.6%
Diabetes mellitus 28 50.9% 18 37.5% 0.17
Hypertension 36 65.5% 24 50.0% 0.11
Chronic kidney disease 7 12.7% 7 14.6% 0.78
Respiratory support:
Simple mask 4 7.3% 1 2.1% 0.018
Reservoir mask 14 25.5% 3 6.3%
High-flow nasal canula 2 3.6% 2 4.2%
NIV 7 12.7% 3 6.3%
IV 28 50.9% 39 81.3%
AKI characteristics:
AKIN 1 10 18.2% 6 12.5% 0.32
AKIN 2 21 38.2% 14 29.2%
AKIN 3 24 43.6% 28 58.3%
Hemodialysis 7 12.7% 4 8.3% 0.47
Recovered kidney function 19 34.5% 18 37.5% 0.75
Laboratory characteristics:
Hemoglobin (g/dl) 12.5 (10.4-14.1) 13.8 (12.5-14.8) 0.027
Total leucocytes (/μl) (x1000) 13.9 (9.8-20.9) 10.9 (7.9-15.6) 0.037
Total lymphocytes (/μl) 857 (488-1,256) 961 (595-1,382) 0.571
Platelets (/μl) (x1000) 250 (221-318) 253 (188-311) 0.999
Serum creatinine (mg/dl)* 1.8 (1.3-2.8) 1.4 (1.3-2.1) 0.256
C-reactive protein (mg/dl) 120 (48-192) 96 (48-192) 0.173
Ferritin (ng/dl) 854 (453-1,000) 648 (361-964) 0.009
D-dimer (ng/dl) 1627 (755-3,970) 847 (390-2,090) 0.020
PaO2/FiO2 at admission 140 (102-244) 142 (100-236) 0.875
Index CT severity 24 (21-25) 20 (15-24) 0.003
Use of norepinephrine 28 50.9 30 62.5 0.320

IQR = interquartile range; SD = standard deviation; NIV = noninvasive ventilation; IV = invasive ventilation; AKIN = acute kidney injury network. PaO2 = partial pressure of oxygen; FiO2 = fraction of inspired oxygen. *Serum creatinine at the time of AKI diagnosis.